CACNA1F (calcium voltage-gated channel subunit alpha1 F)

2016-10-01  

Identity

HGNC
LOCATION
Xp11.23
LOCUSID
ALIAS
AIED,COD3,COD4,CORDX,CORDX3,CSNB2,CSNB2A,CSNBX2,Cav1.4,Cav1.4alpha1,JM8,JMC8,OA2
FUSION GENES

Other Information

Locus ID:

NCBI: 778
MIM: 300110
HGNC: 1393
Ensembl: ENSG00000102001

Variants:

dbSNP: 778
ClinVar: 778
TCGA: ENSG00000102001
COSMIC: CACNA1F

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000102001ENST00000323022O60840
ENSG00000102001ENST00000376251O60840
ENSG00000102001ENST00000376265O60840
ENSG00000102001ENST00000486943H7C549

Expression (GTEx)

0
1
2
3

Pathways

PathwaySourceExternal ID
MAPK signaling pathwayKEGGko04010
Calcium signaling pathwayKEGGko04020
GnRH signaling pathwayKEGGko04912
Alzheimer's diseaseKEGGko05010
MAPK signaling pathwayKEGGhsa04010
Calcium signaling pathwayKEGGhsa04020
GnRH signaling pathwayKEGGhsa04912
Alzheimer's diseaseKEGGhsa05010
Cardiac muscle contractionKEGGhsa04260
Cardiac muscle contractionKEGGko04260
Vascular smooth muscle contractionKEGGhsa04270
Vascular smooth muscle contractionKEGGko04270
Hypertrophic cardiomyopathy (HCM)KEGGko05410
Hypertrophic cardiomyopathy (HCM)KEGGhsa05410
Arrhythmogenic right ventricular cardiomyopathy (ARVC)KEGGko05412
Arrhythmogenic right ventricular cardiomyopathy (ARVC)KEGGhsa05412
Dilated cardiomyopathyKEGGko05414
Dilated cardiomyopathyKEGGhsa05414
Cholinergic synapseKEGGhsa04725
GABAergic synapseKEGGko04727
GABAergic synapseKEGGhsa04727
Serotonergic synapseKEGGhsa04726
Retrograde endocannabinoid signalingKEGGhsa04723
Retrograde endocannabinoid signalingKEGGko04723
Insulin secretionKEGGhsa04911
Adrenergic signaling in cardiomyocytesKEGGhsa04261
Adrenergic signaling in cardiomyocytesKEGGko04261
Oxytocin signaling pathwayKEGGhsa04921
Oxytocin signaling pathwayKEGGko04921
cGMP-PKG signaling pathwayKEGGhsa04022
cGMP-PKG signaling pathwayKEGGko04022
cAMP signaling pathwayKEGGhsa04024
cAMP signaling pathwayKEGGko04024
Renin secretionKEGGhsa04924
Renin secretionKEGGko04924
Muscle contractionREACTOMER-HSA-397014
Aldosterone synthesis and secretionKEGGhsa04925
Aldosterone synthesis and secretionKEGGko04925
Cardiac conductionREACTOMER-HSA-5576891
Phase 0 - rapid depolarisationREACTOMER-HSA-5576892
Phase 2 - plateau phaseREACTOMER-HSA-5576893

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA448871celecoxibChemicalPathwayassociated22336956
PA451846valproic acidChemicalPathwayassociated23407051

References

Pubmed IDYearTitleCitations
364696682023Optic nerve involvement in CACNA1F-related disease: observations from a multicentric case series.0
364696682023Optic nerve involvement in CACNA1F-related disease: observations from a multicentric case series.0
350657302022Strikingly High Myopia in Aland Island Eye Disease.0
356973282022Two novel CACNA1F gene mutations cause two different phenotypes: Aland Eye Disease and incomplete Congenital Stationary Night Blindness.4
361650862022Identification of a novel CACNA1F mutation in a Chinese family with CORDX3.2
361918402022Assessing the Pathogenicity of In-Frame CACNA1F Indel Variants Using Structural Modeling.1
350657302022Strikingly High Myopia in Aland Island Eye Disease.0
356973282022Two novel CACNA1F gene mutations cause two different phenotypes: Aland Eye Disease and incomplete Congenital Stationary Night Blindness.4
361650862022Identification of a novel CACNA1F mutation in a Chinese family with CORDX3.2
361918402022Assessing the Pathogenicity of In-Frame CACNA1F Indel Variants Using Structural Modeling.1
335137522021A Novel Splice-Site Variant in CACNA1F Causes a Phenotype Synonymous with Åland Island Eye Disease and Incomplete Congenital Stationary Night Blindness.7
336688432021Optic Atrophy and Inner Retinal Thinning in CACNA1F-related Congenital Stationary Night Blindness.2
335137522021A Novel Splice-Site Variant in CACNA1F Causes a Phenotype Synonymous with Åland Island Eye Disease and Incomplete Congenital Stationary Night Blindness.7
336688432021Optic Atrophy and Inner Retinal Thinning in CACNA1F-related Congenital Stationary Night Blindness.2
330370742020Functional impact of a congenital stationary night blindness type 2 mutation depends on subunit composition of Ca(v)1.4 Ca(2+) channels.5

Citation

Dessen P

CACNA1F (calcium voltage-gated channel subunit alpha1 F)

Atlas Genet Cytogenet Oncol Haematol. 2016-10-01

Online version: http://atlasgeneticsoncology.org/gene/56376